In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus
Authors:
- Thomas R. FritscheTFThomas R. Fritsche
- Paul R. RhombergPRPaul R. Rhomberg
- Helio S. SaderHSHelio S. Sader
- Ronald N. JonesRJRonald N. Jones
- 1 April 2008
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 60 (4) , 399-403
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Microbiological Features of Vancomycin in the 21st Century: Minimum Inhibitory Concentration Creep, Bactericidal/Static Activity, and Applied Breakpoints to Predict Clinical Outcomes or Detect Resistant StrainsClinical Infectious Diseases, 2006
- Recognition and management of infections caused by vancomycin‐intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA)Internal Medicine Journal, 2005
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesNew England Journal of Medicine, 2005
- Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic OdysseyClinical Infectious Diseases, 2005
- A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective DrugsCurrent Eye Research, 2005
- A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study)Clinical Microbiology and Infection, 2004
- Quality Control Guidelines for MIC Susceptibility Testing of Omiganan Pentahydrochloride (MBI 226), a Novel Antimicrobial PeptideJournal of Clinical Microbiology, 2004
- Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin‐IntermediateStaphylococcus aureusClinical Infectious Diseases, 2004
- Glycopeptide tolerance in Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1998